Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Product Unit Size | Cost | Quantity | Stock |
---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Purity | ≥98% |
---|---|
Formula | C33H59N11O10 |
Formula Wt. | 769.90 |
Solubility | Soluble in water (2 mg/mL), acetonitrile. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
α1-Adrenergic antagonist.
Synthetic steroid used in HRT; PR, AR, glucocor...
Aldose reductase inhibitor.
Imidazole; 14-α demethylase inhibitor.
AMPK activator, D1-4, 5-HT1A/2/3/6/7, M1-5 mACh...
NSAID; NMDA inverse agonist, T-type Ca2+ and Cl...
Mycotoxin that has structural similarity to est...
Triterpenoid
Protein synthesis inhibitor, used to measure pr...
Inhibits NS5A
Fungal metabolite produced by Penicillium speci...
Synthesis impurity
Epoxomicin analog; proteasome inhibitor.
PAK inhibitor.Smo inhibitor.
NSAID; TRPA1 agonist, COX-2 inhibitor.
Synthetic peptide, fibrinogen derivative; glyco...
FLT3, c-Kit, PDGFR inhibitor.
PDE3 inhibitor.
Sulfonamide; folate production inhibitor.